Benjamin W Kelemen, MD
Cardiovascular Disease (Cardiology) · Lebanon
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Dartmouth-Hitchcock Clinic · 1,445 clinicians in this group
Hospitals listed: Cheshire Medical Center · Mary Hitchcock Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kelemen’s office at (603) 650-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A150128 · Delinquent
Licence status: Delinquent · since 2017 · expires 2025-05-31 · Johns Hopkins University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Cheshire Medical CenterKeene, NHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Dartmouth-Hitchcock, which runs 8 hospitals in 2 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Mary Hitchcock Memorial HospitalLebanon, NHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Dartmouth-Hitchcock, which runs 8 hospitals in 2 statesHome of Dartmouth Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 205.9 (174.73 to 237.06) · 363 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative hemorrhage or hematoma rate: 4.05 (3.05 to 5.05) · 5,073 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Abdominal Hysterectomy: 3.351, Oct 2024 – Sep 2025Worse than the national rate — SSI - Colon Surgery: 1.701, Oct 2024 – Sep 2025Worse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.8 (5.6 to 8.3) · 1,183 cases, Jan 2024 – Dec 2024Worse than the national rate — Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies): 16.1 (13.3 to 19.9) · 3,216 cases, Jan 2022 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.374, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.476, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.442, Oct 2024 – Sep 2025
See every measure and the patient survey for Cheshire Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2.01) · 359 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.01 (0.59 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 242 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.3 · 310 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.2 · 100 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 1,100 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,500 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,511 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (0.98 to 5.85) · 345 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.49 (0.81 to 4.17) · 334 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.34 (1 to 19.68) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (0.71 to 9.12) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 104 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.65 (0 to 1.57) · 2,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.1 · 33 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.864 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.469 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 28 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 38.8 · 261 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.6 · 313 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 368 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.6 to 7.8) · 186 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.1 (6.5 to 12.5) · 186 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.4 (8.9 to 14.5) · 2,307 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 710 cases | No different | Jan 2024 – Dec 2024 |
What patients said (443 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Mary Hitchcock Memorial Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 1 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 205.9 (174.73 to 237.06) · 363 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 4.05 (3.05 to 5.05) · 5,073 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Abdominal HysterectomyInfections | 3.351 | Worse | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.701 | Worse | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (5.6 to 8.3) · 1,183 cases | Worse | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 16.1 (13.3 to 19.9) · 3,216 cases | Worse | Jan 2022 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.476 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.442 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.43 to 1.92) · 2,910 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.18 (0.98 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 142 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 506 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 617 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 410 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 4,695 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0.01 to 0.35) · 11,275 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.11 to 0.46) · 12,234 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.73 (3.33 to 6.12) · 5,218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.95 (0.74 to 3.16) · 2,698 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.87 (8.15 to 15.59) · 2,495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.7 (4.32 to 9.07) · 2,632 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.39 to 2.9) · 1,069 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.11 to 0.98) · 9,839 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 64 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.788 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 704 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 727 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 21.4 · 619 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.9 · 717 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 45.6 · 395 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 424 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (9.1 to 12.5) · 1,183 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.2 · 137 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 117 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 2,520 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,796 patients answered, 27% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Coronary angioplasty and stenting | 67 | More than 90% of doctors who do this |
Drugs they prescribed that Part D paid
$6,300
Pharmacies billed $6,300 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 113) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
105 generic and fewer than 11 brand-name prescriptions · $6,300 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clopidogrel | 19 | $365 | $19 |
| Metoprolol | 17 | $184 | $11 |
| Spironolactone | 12 | $117 | $10 |
Year by year
| 2024 | 113 | 36 | 0% (0) | None | $6,300 |
| 2023 | 62 | 18 | 0% (0) | None | $3,999 |
| 2022 | 18 | None | 0% (0) | None | $1,769 |
| 2018 | 16 | None | 0% (0) | 0% | $416 |
| 2017 | 280 | 75 | 7% (20) | None | $17,579 |
| 2016 | 390 | 82 | 8% (30) | None | $17,883 |
| 2015 | 450 | 112 | 8% (35) | None | $24,350 |
| 2014 | 106 | 27 | 14% (15) | None | $6,633 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Metoprolol | 12 | $160 | $13 |
2017: 5 drugs
| Metoprolol | 17 | $367 | $22 |
| Atorvastatin | 13 | $240 | $18 |
| Lisinopril | 16 | $126 | $8 |
| Amlodipine Besylate | 14 | $76 | $5 |
| Triamterene-Hydrochlorothiazid | 11 | $72 | $7 |
2016: 11 drugs
| Atorvastatin | 26 | $396 | $15 |
| Oxycodone | 18 | $348 | $19 |
| Clopidogrel | 46 | $333 | $7 |
| Dipyridamole | 32 | $212 | $7 |
| Ranitidine | 34 | $208 | $6 |
| Metoprolol | 11 | $207 | $19 |
| Amlodipine Besylate | 18 | $99 | $5 |
| Hydrochlorothiazide | 13 | $98 | $8 |
| Losartan | 11 | $70 | $6 |
| Metformin | 12 | $58 | $5 |
| Lisinopril | 11 | $41 | $4 |
2015: 11 drugs
| Atorvastatin | 30 | $315 | $10 |
| Oxycodone | 12 | $272 | $23 |
| Ranitidine | 27 | $162 | $6 |
| Clopidogrel | 27 | $154 | $6 |
| Gabapentin | 16 | $133 | $8 |
| Lisinopril | 27 | $128 | $5 |
| Losartan | 11 | $115 | $10 |
| Dipyridamole | 19 | $111 | $6 |
| Furosemide | 22 | $101 | $5 |
| Metformin | 19 | $90 | $5 |
| Tramadol | 14 | $59 | $4 |
Money from drug and device companies
$182 in 2025
| 2025 | 2 | 2 | None | $182 |
| 2024 | 1 | 1 | None | $100 |
| 2023 | 1 | 1 | None | $201 |
| 2022 | 1 | 14 | None | $244 |
| 2021 | 2 | 4 | None | $89 |
| 2020 | 1 | 2 | None | $48 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | None | $163 | 1 payment
|
| SpectraWAVE | Hypervue Imaging System | $19 | 1 payment
|
See all 2 published payments
| SpectraWAVE | Meals · 2025-10-07 | Hypervue Imaging System | $19 |
| Edwards Lifesciences | Meals · 2025-03-21 | None | $163 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $100
| Abbott Laboratories | Ultreon | $100 | 1 payment
|
2023: $201
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $201 | 1 payment
|
2022: $244
| Boston Scientific | Rotapro | $244 | 14 payments
|
2021: $89
| Boston Scientific | Opticross | $73 | 3 payments
|
| Medtronic | Telescope | $15 | 1 payment
|
2020: $48
| Abbott Laboratories | Perclose Proglide Suture Mediated Closure System | $48 | 2 payments
|
Professional record
- NPI
- 1952677452
- Licence
- CA A150128California A150128: Delinquent · expires 2025-05-31
- Trained
- Johns Hopkins University School of Medicine, 2014
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207RI0011X (207RI0011X); Student in a training program (390200000X)
- Mailing address
- Po Box 810, Hanover, NH, 03755
- NPI first listed
- 2012-03-28
- NPI last updated
- 2025-12-12
- NPI record certified
- 2025-12-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 700 Lawrence Expy, Santa Clara, CA, 95051
This office lists an electronic records connection.